Acri.LISA offers a full range of vision

Article

Bilateral implantation of the Acri.LISA 366D distance-dominant bifocal intraocular lens provides a satisfactory full range of vision.

Bilateral implantation of the Acri.LISA 366D distance-dominant bifocal intraocular lens (IOL) provides a satisfactory full range of vision, according to the results of a study published in the November issue of the Journal of Cataract and Refractive Surgery.

José Alfonso and colleagues from the Fernández-Vega Ophthalmological Institute, Oviedo, Spain bilaterally implanted the Acri.LISA 366D IOL in 81 patients. Monocular and binocular best corrected visual acuity and best distance corrected near visual acuity, binocular best distance corrected intermediate visual acuity and distance contrast sensitivity under photopic and mesopic conditions were determined.

At three months follow-up, the mean binocular best corrected distance visual acuity was 0.048±0.111 logMAR and the mean binocular best distance corrected near acuity was 0.012±0.0084 logMAR. The mean binocular best distance corrected intermediate acuity changed significantly as a function of the distance of the test from 0.012±0.084 logMAR at 33 cm to 0.265±0.099 logMAR at 70 cm (p<0.01). Contrast sensitivity was within normal limits under photopic and mesopic conditions.

These results demonstrate that the Acri.LISA 366D IOL offers a good full range of vision.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.